Dr Emma Sceats of organ-on-a-chip firm CN Bio Innovations wins Innovate UK’s infocus Women in Innovation award
Welwyn Garden City, UK- 15th November 2016: Following a nationwide competition, CEO of London bioengineering firm CN Bio Innovations Dr Emma Sceats has been named as a winner of Innovate UK’s infocus Women in Innovation award. The awards will be celebrated as part of...
MIT and CN Bio Innovations today announced that the world’s first 7-organ “Human-on-a-Chip” platform will be showcased at the Organ-on-Chip congress in Boston on the 7th and 8th of July 2016. Under a $26M Defense Advanced Research Projects Agency (DARPA) contract...
CN Bio Innovations Ltd, an expert in developing human organs-on-chips to test and develop therapeutics for serious diseases, is proud to be the platinum sponsor of SelectBio’s 2nd Annual Organ-on-a-Chip world Congress in Boston on the 7th and 8th of July. The...
CN Bio Innovations are delighted to announce the appointment of Dr Emma Sceats as Chief Executive effective 1st January 2016. Dr David Scales will remain on the board as an advisor to the company with particular emphasis on new business opportunities.
Imperial College London to present HBV data on CN Bio immune-competent liver model at AASLD The Liver Meeting
CN Bio Innovations Ltd, an expert in developing human organ chip platforms to test and develop therapeutics for serious diseases, has announced that new data from its research collaboration with Imperial College London, where the team are analysing a novel human, full-viral-lifecycle model of Hepatitis B, will be presented in the late-breaking poster session at The Liver Meeting® 2015, San Francisco USA (13-17 November, 2015).
Dr David Hughes has been appointed to the board of directors, effective immediately. He will also continue with his responsibility for overseeing management of all technical projects and alliances with CN Bio partners as well as managing the internal scientific and engineering teams.
CN Bio Innovations features in Al Jazeera documentary “The Cure”.
CN Bio Innovations, an expert in developing human organ-on-a-chip platforms, was featured in the 10 August 2015 broadcast of The Cure, an Al Jazeera network (AJN) documentary which looks at some of the world’s most intractable health problems.
CN Bio’s COO, Dr Emma Sceats, interviewed for BBC Impact.
Towards a body on a chip.